MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
146 hedge funds and large institutions have $638M invested in Momenta Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 35 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
-2
Holders Change %
-1.35%
% of All Funds
3.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
65
Reduced
35
Closed
23
Calls
$2.69M
Puts
$296K
Net Calls
+$2.4M
Net Calls Change
+$1.96M
Top Buyers
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$26M |
| 2 |
NRC
North Run Capital
Boston,
Massachusetts
|
+$7.78M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$6.85M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.87M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$2.69M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$7.17M |
| 2 |
State Street
Boston,
Massachusetts
|
-$5M |
| 3 |
SAM
Senzar Asset Management
New York
|
-$4.23M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.95M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.33M |
